Market Place
Sourcing Support
Enforcement Report - Week of May 22, 2024
22 May 2024 //
FDA
Enforcement Report - Week of November 8, 2023
08 Nov 2023 //
FDA
Granules India Received ANDA Approval for Losartan and HCL Tablets
30 Sep 2023 //
PRESS RELEASE
Enforcement Report - Week of January 25, 2023
25 Jan 2023 //
FDA
Zydus Lifesciences gets USFDA nod for generic hypertension drug
08 Nov 2022 //
HEALTH ET
Enforcement Report - Week of November 2, 2022
02 Nov 2022 //
FDA
Enforcement Report - Week of August 17, 2022
17 Aug 2022 //
FDA
Enforcement Report - Week of April 13, 2022
13 Apr 2022 //
FDA
Pfizer Canada recalls BP drug on potential cancer-causing impurity
05 Mar 2022 //
HEALTH CANADA
Glenmark Pharm receives US FDA approval for generic Ziac tablets
27 Jan 2022 //
PHARMABIZ
Enforcement Report - Week of December 22, 2021
22 Dec 2021 //
FDA
Daiichi Sankyo’s triple combo drug shows promising real-world clinical data
24 Nov 2021 //
KOREABIOMED
Enforcement Report - Week of November 11, 2021
10 Nov 2021 //
FDA
FDA approves label changes to hydrochlorothiazide to describe small risk
24 Aug 2020 //
CISION
FDA approves label changes to hydrochlorothiazide to describe small risk
20 Aug 2020 //
FDA
Application of polyvinyl acetate in an innovative formulation strategy
19 Aug 2020 //
PHARMAEXCIPIENTS
Edenbridge`s Generic Bisoprolol Fumarate;Hydrochlorothiazide Approval in US
16 Jul 2020 //
FDA
AstraZeneca hawks suite of hypertension drugs for $350M in latest asset sale
03 Mar 2020 //
FIERCE PHARMA
FDA tags Torrent as key offender in production of tainted blood pressure meds
17 Oct 2019 //
FIERCE PHARMA
Glenmark Pharma terms report on stake sale to PremjiInvest speculative
27 Aug 2019 //
INDIAINFOLINE
Glenmark recalls products from US market
26 Aug 2019 //
ECONOMICTIMES
Enforcement Report - Week of August 21, 2019
21 Aug 2019 //
FDA
Enforcement Report - Week of July 31, 2019
31 Jul 2019 //
FDA
Enforcement Report - Week of July 17, 2019
17 Jul 2019 //
FDA
Fourth Carcinogen Discovered in Heart Pills Used by Millions
19 Jun 2019 //
BLOOMBERG
Enforcement Report - Week of May 8, 2019
08 May 2019 //
FDA
NPPA fixes retail prices of 22 formulations under DPCO, 2013
06 May 2019 //
PHARMABIZ
EMA Urges Pioglitazone Manufacturers to Check for Nitrosamine Impurities
26 Apr 2019 //
RAPS
Enforcement Report - Week of March 27, 2019
27 Mar 2019 //
FDA
To Prevent Losartan Shortages, FDA Allows Higher Impurity Levels
22 Mar 2019 //
RAPS
FDA updates on recalls of valsartan, losartan and irbesartan
20 Mar 2019 //
FDA
Zydus Pharm USA`s Generic HCTZ; Triamterene Receives Approval in US
11 Feb 2019 //
FDA
Enforcement Report - Week of February 6, 2019
06 Feb 2019 //
FDA
Important new safety information regarding the use of hydrochlorothiazide and the risk of non-melanoma skin cancer
03 Feb 2019 //
HEALTH CANADA
Losartan products under recall - Updated January 22, 2019
23 Jan 2019 //
FDA
Enforcement Report - Week of January 23, 2019
23 Jan 2019 //
FDA
Torrent Pharmaceuticals Recalls Losartan Potassium and Losartan/HCTZ Tablets
23 Jan 2019 //
FDA
Irbesartan products under recall - Updated January 18, 2019
19 Jan 2019 //
FDA
Sciegen Pharms` Generic Hydrochlorothiazide Receives Approval in US
14 Jan 2019 //
FDA
A wave of drug recalls hits Indian pharma firms in US
09 Jan 2019 //
DNA INDIA
Irbesartan blood pressure and heart medication recalled from pharmacies by MHRA
03 Jan 2019 //
GOV UK
Class 2 Medicines Recall: Actavis recall of batches of Irbesartan / HCTZ Tablets
03 Jan 2019 //
GOV UK
FDA issues alert, voluntary recall on cardiovascular medication
28 Dec 2018 //
MASSACHUSETTS LIVE
